By: Christopher A. Parrella, Esq., CPC, CHC, CPCO
Parrella Health Law, Boston, Ma.
A Health Care Defense and Compliance Firm

The realm of healthcare law is ever-evolving, with the case of Ward v. Schaefer offering critical insights into the complexities surrounding informed consent, especially in the context of experimental treatments. On January 29, 2024, the First Circuit delivered a pivotal decision, refusing to order a new trial for a lack of informed consent claim against Dr. Ernst J. Schaefer, highlighting the nuanced interpretations of physician responsibilities under Massachusetts law.

The Case Overview

Edmund Edward Ward, afflicted with a rare genetic deficiency impacting cholesterol production and leading to severe kidney issues, sought experimental enzyme therapy through the National Institutes of Health (NIH), referred by Dr. Schaefer. Despite the innovative approach, the treatment did not halt the progression of Ward’s condition, eventually necessitating dialysis. The legal battle ensued when Ward accused Dr. Schaefer of fraudulently inducing participation in the NIH experimental protocol without proper informed consent. The jury sided with Dr. Schaefer, a decision upheld by the First Circuit, further solidified by the denial of Ward’s motion for a new trial.

Key Legal Takeaways

The First Circuit’s decision underscores several crucial aspects of healthcare law:

The Scope of Informed Consent: The court’s deliberation on whether Dr. Schaefer, who did not administer the treatment but monitored Ward’s condition, had a duty to obtain informed consent for an experimental protocol provides a significant precedent. The ruling aligns with Massachusetts law, indicating that a physician’s role in patient care must be primary or lead to necessitate informed consent for treatment.

Relevance of Scientific Evidence: The court’s refusal to admit the experimental enzyme therapy’s patent into evidence due to its minimal relevance against a “sea of unrelated information” emphasizes the challenge of balancing scientific detail with legal standards. This highlights the judiciary’s careful navigation through complex scientific evidence to ensure justice.

Physician-Patient Relationship Dynamics: This case illustrates the evolving dynamics of the physician-patient relationship, especially in the context of experimental therapies. The distinction made by the court regarding the nature of involvement a physician has in the patient’s care vis-à-vis informed consent requirements offers essential guidance for healthcare practitioners.

Implications for Healthcare Providers

Ward v. Schaefer serves as a crucial reminder for healthcare providers about the importance of clear communication and thorough informed consent processes, especially when dealing with experimental treatments. Physicians must understand their legal obligations and ensure patients are fully informed of the risks, benefits, and alternatives to experimental therapies. This case also signals to healthcare providers the importance of documenting patient interactions and consent processes meticulously.

Conclusion

The First Circuit’s decision in Ward v. Schaefer provides valuable lessons for healthcare providers and legal professionals alike. It underscores the importance of informed consent, especially in the rapidly advancing field of experimental medicine. As healthcare law continues to evolve, Parrella Health Law remains committed to offering expert guidance and support to healthcare providers navigating these complex legal landscapes.

For any inquiries or assistance regarding informed consent or other healthcare legal matters, do not hesitate to contact Parrella Health Law. We are ready to speak with you at 857-328-0382 or respond to any emails sent to info@parrellahealthlaw.com. Our expertise is your safeguard in navigating the intricacies of healthcare law and compliance.

Christopher Parrella, ESQ, CPC, CHC, CPCO, is the founding partner of Parrella Health Law in Boston, Mass. The firm focuses exclusively on healthcare defense and compliance matters. Chris also travels the country on behalf of a wide range of healthcare organizations, lecturing on a variety of health care enforcement and compliance topics. Chris is one of a handful of health care attorney’s that are also Certified Professional Coders (CPC) and is a member of the AAPC’s National Legal Advisory Board and Ethics Committee.  He is also a Certified Professional Compliance Officer (CPCO) and Certified in Health Care Compliance (CHC.)